Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Decibel Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
DBTX is no longer listed, so this page shows Q2 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 37
- −1 vs. Q1 2023
- Shares held
- 15.4M
- −70.2K (−0.5%) vs. Q1 2023
- Total value
- $59.2M
- +$12.6M (+26.9%) vs. Q1 2023
- New holders
- 3
- 6 more added
- Sold out
- 4
- 9 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cubist Systematic Strategies, LLC | 10 | $39 | 0.00% | −561−98.2% | Reduced |
| Wells Fargo & Company | 94 | $362 | 0.00% | +4+4.4% | Added |
| Royal Bank of Canada | 722 | $3.00K | 0.00% | −316−30.4% | Reduced |
| UBS Group AG | 1,735 | $6.68K | 0.00% | +1,689+3,671.7% | Added |
| Tower Research Capital LLC (TRC) | 2,867 | $11.0K | 0.00% | −2,226−43.7% | Reduced |
| Lazard Asset Management LLC | 3,970 | $15.0K | 0.00% | +3,970 | New |
| Morgan Stanley | 6,600 | $25.4K | 0.00% | −9,526−59.1% | Reduced |
| Flagship Harbor Advisors, LLC | 10,113 | $38.9K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 10,600 | $40.8K | 0.00% | +10,600 | New |
| Barclays PLC | 10,855 | $41.8K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 11,990 | $46.2K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 14,900 | $57.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 19,091 | $73.5K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 20,000 | $77.0K | 0.00% | 00.0% | Unchanged |
| Atlas Capital Advisors LLC | 25,000 | $96.3K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 34,400 | $132.0K | 0.00% | +1,900+5.8% | Added |
| Dimensional Fund Advisors LP | 34,607 | $133.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 40,489 | $155.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 40,960 | $157.7K | 0.00% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 41,960 | $161.5K | 0.09% | +41,960 | New |
| Neuberger Berman Group LLC | 58,800 | $226.4K | 0.00% | +43,139+275.5% | Added |
| Geode Capital Management, LLC | 115,567 | $444.9K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 116,981 | $450.4K | 0.00% | −8,680−6.9% | Reduced |
| Bridgeway Capital Management, LLC | 119,100 | $458.5K | 0.01% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 132,000 | $508.2K | 0.00% | 00.0% | Unchanged |
| Bronte Capital Management Pty Ltd. | 154,878 | $596.3K | 0.06% | −2,577−1.6% | Reduced |
| Millennium Management LLC | 159,224 | $613.0K | 0.00% | −87,093−35.4% | Reduced |
| UBS Oconnor LLC | 199,200 | $766.9K | 0.02% | +9,814+5.2% | Added |
| Newtyn Management, LLC | 200,000 | $770.0K | 0.18% | −53,818−21.2% | Reduced |
| Harvard Management Co Inc | 326,029 | $1.25M | 0.12% | −2,769−0.8% | Reduced |
| Bessemer Group Inc | 494,071 | $1.90M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 642,325 | $2.47M | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 801,629 | $3.09M | 0.54% | 00.0% | Unchanged |
| Alphabet Inc. | 1,636,258 | $6.30M | 0.34% | 00.0% | Unchanged |
| BlackRock Inc. | 1,811,483 | $6.97M | 0.00% | +5,337+0.3% | Added |
| TRV GP III, LLC | 3,139,685 | $12.1M | 66.29% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,945,192 | $19.0M | 0.37% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −19,783−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Financial Connections Group, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |